Background: Orthotopic heart transplantation (HTx) is a long-term surgical therapeutic
approach for patients with end-stage heart failure. The objective of the present study was to …

Objectives Thyroid dysfunction has been shown to be associated with increased all-cause
mortality and severity of chronic heart failure in critical illness and severe cardiac diseases …

Objectives To investigate whether recipient administration of thyroid hormone (liothyronine
[T3]) is associated with reduced rates of primary graft dysfunction (PGD) after orthotopic …

Objective The effect of thyroid dysfunction on adverse outcomes has been studied in many
different patient populations. The objective of this study was to investigate the effect of …

Background Heart transplant recipients suffer from depletions in triiodothyronine, despite the
absence of thyroid dysfunction, which may contribute to delayed graft function. Little is …

In clinical heart transplantation, the heart is procured from brain dead (BD) organ donors
who acutely experienced a variety of critical illnesses. In all of these conditions, a profound …

Purpose: To investigate the impact of TSH levels using a more stringent cutoff of subclinical
hypothyroidism (ie, TSH> 2.5 mIU/L) on the short-term complications and long-term …

Background Orthotopic heart transplantation (HTX) is the gold standard to treat end-stage
heart failure. Numerous risk stratification tools have been developed in the past years …

Background Thyroid hormones are essential for the correct functioning of the entire body.
Diagnosis of thyroid disorders in patients after heart transplant in the early post-operative …

Purpose To estimate the impact and the frequency of development thyroid disorders (TD)
after heart transplantation (HT). Methods From 2010 to 2016 we performed 80 HT (mean …